ARCA gets FDA approval of IND for Covid-19 drug candidate AB201
This article was originally published here
With the IND approval in place, the company expects to launch a phase 2b/3 sequential clinical trial of AB201 in the fourth quarter of 2020. The phase 2b
The post ARCA gets FDA approval of IND for Covid-19 drug candidate AB201 appeared first on Pharmaceutical Business review.
Leave a Reply
Want to join the discussion?Feel free to contribute!